CompoAtlas

PREVENTLIFE REGLES DOULOUREUSES

Food supplement declared in France, declaration No 2022-7-204, decision dated 5 July 2022

PREVENTLIFE REGLES DOULOUREUSES is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
SAS S.I.D. NUTRITION
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
3 COMPRIMES
Directions for use
CF CI DESSOUS
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Cycles féminins

Declaration 185439, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Alchemilla vulgaris L.Parties aériennesExtrait sec aqueux765 mg
Achillea millefolium L.Parties aériennesExtrait sec aqueux450 mg
Vitex agnus-castus L.FruitPoudre (de plantes séchées ou broyées)150 mg
Adansonia digitata L.Fruit (pulpe)Poudre (de plantes séchées ou broyées)75 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E414, E341, E470b

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

MODE D'EMPLOI : La veille ou le premier jour des règles, prendre 1 comprimé avec un grand verre d'eau. Pendant les règles, prendre 1 à 3 comprimés par jour selon l'intensité de l'inconfort avec un grand verre d'eau.CONSOMMATION DECONSEILLEE : Déconseillé aux femmes ayant des antécédents personnels ou familiaux de cancer du sein, ainsi qu'aux femmes allaitantes. Il est recommandé aux femmes enceintes de consulter un professionnel de santé avant toute complémentation.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vitex agnus-castus L.
    Read the warning, when it applies and the studies cited

    CHASTE TREE - VITEX AGNUS-CASTUS

    Route of administration: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line